291
Views
14
CrossRef citations to date
0
Altmetric
Original Article

Sex- and age-specific associations between major depressive disorder and metabolic syndrome in two general population samples in Germany

, , , , , , , , , , , & show all
Pages 611-620 | Received 02 Dec 2015, Accepted 13 May 2016, Published online: 14 Jun 2016

References

  • Vitaliano PP, Scanlan JM, Zhang J, Savage MV, Hirsch IB, Siegler IC. A path model of chronic stress, the metabolic syndrome, and coronary heart disease. Psychosom Med 2002;64:418–35.
  • Musselman D, Evans D, Nemeroff C. The relationship of depression to cardiovascular disease: Epidemiology, biology, and treatment. Arch Gen Psychiatry 1998;55:580–92.
  • Vaccarino V, McClure C, Johnson BD, Sheps DS, Bittner V, Rutledge T, et al. Depression, the metabolic syndrome and cardiovascular risk. Psychosom Med 2008;70:40–8.
  • Knol M, Twisk J, Beekman A, Heine R, Snoek F, Pouwer F. Depression as a risk factor for the onset of type 2 diabetes mellitus. A meta-analysis. Diabetologia 2006;49:837–45.
  • Carney RM, Freedland KE, Miller GE, Jaffe AS. Depression as a risk factor for cardiac mortality and morbidity: A review of potential mechanisms. J Psychosom Res 2002;53:897–902.
  • van Vliet-Ostaptchouk J, Nuotio M-L, Slagter S, Doiron D, Fischer K, Foco L, et al. The prevalence of metabolic syndrome and metabolically healthy obesity in Europe: a collaborative analysis of ten large cohort studies. BMC Endocr Disord 2014;14:9–22.
  • Krane-Gartiser K, Breum L, Glümer C, Linneberg A, Madsen M, Køster A, et al. Prevalence of the metabolic syndrome in Danish psychiatric outpatients treated with antipsychotics. Nord J Psychiatry 2011;65:345–52.
  • Vinberg M, Madsen M, Breum L, Kessing LV, Fink-Jensen A. Metabolic syndrome in a cohort of affectively ill patients, a naturalistic study. Nord J Psychiatry 2012;66:142–5.
  • Rhee SJ, Kim EY, Kim SH, Lee HJ, Kim B, Ha K, et al. Subjective depressive symptoms and metabolic syndrome among the general population. Prog Neuropsychopharmacol Biol Psychiatry 2014;54:223–30.
  • Seppälä J, Vanhala M, Kautiainen H, Eriksson J, Kampman O, Mantyselka P, et al. Prevalence of Metabolic Syndrome in subjects with melancholic and non-melancholic depressive symptoms. A Finnish population-based study. J Affect Disord 2011;136:543–9.
  • Nishina M, Nishina K, Ohira T, Makino K, Iso H. Associations of psychological distress with metabolic syndrome among Japanese urban residents. J Atheroscler Thromb 2011;18:396–402.
  • Hildrum B, Mykletun A, Midthjell K, Ismail K, Dahl AA. No association of depression and anxiety with the metabolic syndrome: The Norwegian HUNT study. Acta Psychiatr Scand 2009;120:14–22.
  • Grimaldi S, Englund A, Partonen T, Haukka J, Pirkola S, Reunanen A, et al. Experienced poor lighting contributes to the seasonal fluctuations in weight and appetite that relate to the metabolic syndrome. J Environ Public Health 2009;2009:11.
  • Rintamäki R, Grimaldi S, Englund A, Haukka J, Partonen T, Reunanen A, et al. Seasonal changes in mood and behavior are linked to metabolic syndrome. PLoS One 2008;3:e1482.
  • Dunbar JA, Reddy P, Davis-Lameloise N, Philpot B, Laatikainen T, Kilkkinen A, et al. Depression: an important comorbidity with metabolic syndrome in a general population. Diabetes Care 2008;31:2368–73.
  • Pannier B, Thomas F, Eschwège E, Bean K, Benetos A, Leocmach Y, et al. Cardiovascular risk markers associated with the metabolic syndrome in a large French population: The study. Diabetes Metab 2006;32:467–74.
  • van Reedt Dortland AK, Giltay EJ, van Veen T, Zitman FG, Penninx BW. Metabolic syndrome abnormalities are associated with severity of anxiety and depression and with tricyclic antidepressant use. Acta Psychiatr Scand 2010;122:30–9.
  • Foley DL, Morley KI, Madden PA, Heath AC, Whitfield JB, Martin NG. Major depression and the metabolic syndrome. Twin Res Hum Genet 2010;13:347–58.
  • Pan A, Keum N, Okereke OI, Sun Q, Kivimaki M, Rubin RR, et al. Bidirectional association between depression and metabolic syndrome: A systematic review and meta-analysis of epidemiological studies. Diabetes Care 2012;35:1171–80.
  • Kessler RC, McGonagle KA, Swartz M, Blazer DG, Nelson CB. Sex and depression in the national comorbidity survey I: Lifetime prevalence, chronicity and recurrence. J Affect Disord 1993;29:85–96.
  • Marijnissen RM, Smits JEMP, Schoevers RA, van den Brink RHS, Holewijn S, Franke B, et al. Association between metabolic syndrome and depressive symptom profiles-sex-specific? J Affect Disord 2013;151:1138–42.
  • Toker S, Shirom A, Melamed S. Depression and the metabolic syndrome: Gender-dependent associations. Depress Anxiety 2008;25:661–9.
  • Skilton MR, Moulin P, Terra JL, Bonnet F. Associations between anxiety, depression, and the metabolic syndrome. Biol Psychiatry 2007;62:1251–7.
  • Kinder LS, Carnethon MR, Palaniappan LP, King AC, Fortmann SP. Depression and the metabolic syndrome in young adults: Findings from the third national health and nutrition examination survey. Psychosom Med 2004;66:316–22.
  • Schipf S, Alte D, Völzke H, Friedrich N, Haring R, Lohmann T. Prävalenz des Metabolischen Syndroms in Deutschland: Ergebnisse der Study of Health in Pomerania (SHIP). Diabetol Stoffwechs 2010;5:161–8.
  • Regitz-Zagrosek V, Lehmkuhl E, Weickert MO. Gender differences in the metabolic syndrome and their role for cardiovascular disease. Clin Res Cardiol 2006;95:136–47.
  • Gil K, Radzillowicz P, Zdrojewski T, Pakalska-Korcala A, Chwojnicki K, Piwonski J, et al. Relationship between the prevalence of depressive symptoms and metabolic syndrome. Results of the SOPKARD project. Kardiol Pol 2006;64:464–9.
  • Beigh SH, Jain S. Prevalence of metabolic syndrome and gender differences. Bioinformation 2012;8:613–6.
  • Mozumdar A, Liguori G. Persistent increase of prevalence of metabolic syndrome among U.S. adults: NHANES III to NHANES 1999-2006. Diabetes Care 2011;34:216–9.
  • Kuk JL, Ardern CI. Age and sex differences in the clustering of metabolic syndrome factors: Association with mortality risk. Diabetes Care 2010;33:2457–61.
  • McIntyre R, Rasgon N, Kemp D, Nguyen H, Law C, Taylor V, et al. Metabolic syndrome and major depressive disorder: Co-occurrence and pathophysiologic overlap. Curr Diab Rep 2009;9:51–9.
  • Allison DB, Newcomer JW, Dunn AL, Blumenthal JA, Fabricatore AN, Daumit GL, et al. Obesity among those with mental disorders: A national institute of mental health meeting report. Am J Prev Med 2009;36:341–50.
  • Heo M, Pietrobelli A, Fontaine KR, Sirey JA, Faith MS. Depressive mood and obesity in US adults: Comparison and moderation by sex, age, and race. Int J Obes (Lond) 2005;30:513–19.
  • Muldoon MF, Mackey RH, Korytkowski MT, Flory JD, Pollock BG, Manuck SB. The metabolic syndrome is associated with reduced central serotonergic responsivity in healthy community volunteers. J Clin Endocrinol Metab 2006;91:718–21.
  • Demirci H, Cinar Y, Bilgel N. Metabolic syndrome and depressive symptoms in a primary health care setting in Turkey. BCP 2011;21:49–57.
  • Goldbacher EM, Bromberger J, Matthews KA. Lifetime history of major depression predicts the development of the metabolic syndrome in middle-aged women. Psychosom Med 2009;71:266–72.
  • NCEP. Third report of the national cholesterol education program (NCEP) Expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation 2002;106:3143–421.
  • IDF. The International Diabetes Federation consensus worldwide definition of the Metabolic Syndrome. Available: http://www.idf.org/home/index.cfm?node =1429; 2005 [updated 2005; cited 2008 Oct, 7].
  • Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA, et al. Diagnosis and management of the metabolic syndrome: An American heart association/national heart, lung, and blood institute scientific statement. Circulation 2005;112:2735–52.
  • Völzke H, Alte D, Schmidt CO, Radke D, Lorbeer R, Friedrich N, et al. Cohort profile: The study of health in Pomerania. Int J Epidemiol 2011;40:294–307.
  • Grabe HJ, Lange M, Wolff B, Volzke H, Lucht M, Freyberger HJ, et al. Mental and physical distress is modulated by a polymorphism in the 5-HT transporter gene interacting with social stressors and chronic disease burden. Mol Psychiatry 2005;10:220–4.
  • John U, Greiner B, Hensel E, Ludemann J, Piek M, Sauer S, et al. Study of health in Pomerania (SHIP): A health examination survey in an east German region. Objectives and design. Soz Praventivmed 2001;46:186–94.
  • Wittchen H, Höfler M, Gander F, Pfister H, Storz S, Üstün B, et al. Screening for mental disorders: Performance of the composite international diagnostic-screener (CID-S). Int J Meth Psychiat Res 1999;8:59–70.
  • Grabe HJ, Baumeister SE, John U, Freyberger HJ, Volzke H. Association of mental distress with health care utilization and costs: A 5-year observation in a general population. Soc Psychiatry Psychiatr Epidemiol 2009;44:835–44.
  • Wittchen HU, H P. DIA-X-Interviews: Manual für Screening-Verfahren und Interview: (a) Interviewheft Längsschnittuntersuchung (DIA-X-Lifetime); (b) Ergänzungsheft (DIA-X-Lifetime); (c) Interviewheft Querschnittuntersuchung (DIA-X-12 Monate); (d) Ergänzungsheft (DIA-X-12 Monate); (e) PCProgramm zur Durchführung des Interviews (Längs- und Querschnittuntersuchung); (f) Auswertungsprogramm. Frankfurt: Swets & Zeitlinger; 1997.
  • Lidfeldt J, Nyberg P, Nerbrand C, Samsioe G, Schersten B, Agardh CD. Socio-demographic and psychosocial factors are associated with features of the metabolic syndrome. The women's health in the lund area (WHILA) study. Diabetes Obes Metab 2003;5:106–12.
  • Saunders J, Aasland O, Babor T, de la Fuente J, Grant M. Development of the alcohol use disorders identification test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993;88:791–804.
  • Baecke JA, Burema J, Frijters JE. A short questionnaire for the measurement of habitual physical activity in epidemiological studies. Am J Clin Nutr 1982;36:936–42.
  • Organization WH. Anatomical Therapeutic Chemical/Defined Daily Dose Classification (ATC) Structure and principles. 2011; Available from: http://www.whocc.no/atc/structure_and_principles/.
  • Vanhala M, Jokelainen J, Keinanen-Kiukaanniemi S, Kumpusalo E, Koponen H. Depressive symptoms predispose females to metabolic syndrome: A 7-year follow-up study. Acta Psychiatr Scand 2009;119:137–42.
  • Viinamaki H, Heiskanen T, Lehto SM, Niskanen L, Koivumaa-Honkanen H, Tolmunen T, et al. Association of depressive symptoms and metabolic syndrome in men. Acta Psychiatr Scand 2009;120:23–9.
  • Laudisio A, Marzetti E, Pagano F, Pozzi G, Bernabei R, Zuccala G. Depressive symptoms and metabolic syndrome: Selective association in older women. J Geriatr Psychiatry Neurol 2009;22:215–22.
  • Herva A, Rasanen P, Miettunen J, Timonen M, Laksy K, Veijola J, et al. Co-occurrence of metabolic syndrome with depression and anxiety in young adults: The Northern Finland 1966 birth cohort study. Psychosom Med 2006;68:213–16.
  • Pulkki-Raback L, Elovainio M, Kivimaki M, Mattsson N, Raitakari OT, Puttonen S, et al. Depressive symptoms and the metabolic syndrome in childhood and adulthood: A prospective cohort study. J Health Psychol 2009;28:108–16.
  • Moebus S, Hanisch J, Aidelsburger P, Bramlage P, Wasem J, Jockel K-H. Impact of 4 different definitions used for the assessment of the prevalence of the metabolic syndrome in primary health care: The German metabolic and cardiovascular risk project (GEMCAS). Cardiovasc Diabetol 2007;6:22–34.
  • Ford ES, Giles WH, Dietz WH. Prevalence of the metabolic syndrome among US adults: Findings from the third national health and nutrition examination survey. JAMA 2002;287:356–9.
  • Diniz BS, Reynolds CF. Major depressive disorder in older adults: Benefits and hazards of prolonged treatment. Drugs Aging 2014;31:661–9.
  • Alemany M. Do the interactions between glucocorticoids and sex hormones regulate the development of the metabolic syndrome? Front Endocrinol (Lausanne) 2012;3:27
  • Soares CN, Zitek B. Reproductive hormone sensitivity and risk for depression across the female life cycle: A continuum of vulnerability? J Psychiatry Neurosci 2008;33:331–43.
  • Schüle C, Baghai TC, Rupprecht R. Neue Erkenntnisse zur Pathogenese und Pathophysiologie der Depression. Nervenarzt 2007;78:531–50.
  • van Broekhoven F, Verkes R. Neurosteroids in depression: A review. Psychopharmacology 2003;165:97–110.
  • Weber-Hamann B, Werner M, Hentschel F, Bindeballe N, Lederbogen F, Deuschle M, et al. Metabolic changes in elderly patients with major depression: Evidence for increased accumulation of visceral fat at follow-up. Psychoneuroendocrinology 2006;31:347–54.
  • Miettola J, Niskanen LK, Viinamaki H, Kumpusalo E. Metabolic syndrome is associated with self-perceived depression. Scand J Prim Health Care 2008;26:203–10.
  • Everson-Rose SA, Lewis TT, Karavolos K, Dugan SA, Wesley D, Powell LH. Depressive symptoms and increased visceral fat in middle-aged women. Psychosom Med 2009;71:410–16.
  • Bornstein SR, Schuppenies A, Wong ML, Licinio J. Approaching the shared biology of obesity and depression: The stress axis as the locus of gene-environment interactions. Mol Psychiatry 2006;11:892–902.
  • Luppino FS, van Reedt Dortland AK, Wardenaar KJ, Bouvy PF, Giltay EJ, Zitman FG, et al. Symptom dimensions of depression and anxiety and the metabolic syndrome. Psychosom Med 2011;73:257–64.
  • Kloiber S, Kohli MA, Brueckl T, Ripke S, Ising M, Uhr M, et al. Variations in tryptophan hydroxylase 2 linked to decreased serotonergic activity are associated with elevated risk for metabolic syndrome in depression. Mol Psychiatry 2010;15:736–47.
  • Park Y-W, Zhu S, Palaniappan L, Heshka S, Carnethon M, Heymsfield S. The metabolic syndrome: Prevalence and associated risk factor findings in the US population from the third national health and nutrition examination survey, 1988-1994. Arch Intern Med 2003;163:427–36.
  • Völzke H, Ittermann T, Schmidt CO, Baumeister SE, Schipf S, Alte D, et al. Prevalence trends in lifestyle-related risk factors. Dtsch Arztebl International 2015;112:185–92.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.